sodium-acetate--anhydrous and Diabetic-Ketoacidosis

sodium-acetate--anhydrous has been researched along with Diabetic-Ketoacidosis* in 3 studies

Trials

1 trial(s) available for sodium-acetate--anhydrous and Diabetic-Ketoacidosis

ArticleYear
0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trial.
    Critical care (London, England), 2020, 01-02, Volume: 24, Issue:1

    Acute kidney injury (AKI) is an important complication encountered during the course of diabetic ketoacidosis (DKA). Plasma-Lyte with lower chloride concentration than saline has been shown to be associated with reduced incidence of AKI in adults with septic shock. No study has compared this in DKA.. This double-blind, parallel-arm, investigator-initiated, randomized controlled trial compared 0.9% saline with Plasma-Lyte-A as initial fluid in pediatric DKA. The study was done in a tertiary care, teaching, and referral hospital in India in children (> 1 month-12 years) with DKA as defined by ISPAD. Children with cerebral edema or known chronic kidney/liver disease or who had received pre-referral fluids and/or insulin were excluded. Sixty-six children were randomized to receive either Plasma-Lyte (n = 34) or 0.9% saline (n = 32).. Primary outcome was incidence of new or progressive AKI, defined as a composite outcome of change in creatinine (defined by KDIGO), estimated creatinine clearance (defined by p-RIFLE), and NGAL levels. The secondary outcomes were resolution of AKI, time to resolution of DKA (pH > 7.3, bicarbonate> 15 mEq/L & normal sensorium), change in chloride, pH and bicarbonate levels, proportion of in-hospital all-cause mortality, need for renal replacement therapy (RRT), and length of ICU and hospital stay.. Baseline characteristics were similar in both groups. The incidence of new or progressive AKI was similar in both [Plasma-Lyte 13 (38.2%) versus 0.9% saline 15 (46.9%); adjusted OR 1.22; 95% CI 0.43-3.43, p = 0.70]. The median (IQR) time to resolution of DKA in Plasma-Lyte-A and 0.9% saline were 14.5 (12 to 20) and 16 (8 to 20) h respectively. Time to resolution of AKI was similar in both [Plasma-Lyte 22.1 versus 0.9% saline 18.8 h (adjusted HR 1.72; 95% CI 0.83-3.57; p = 0.14)]. Length of hospital stay was also similar in both [Plasma-Lyte 9 (8 to 12) versus 0.9% saline 10 (8.25 to 11) days; p = 0.39].. The incidence of new or progressive AKI and resolution of AKI were similar in both groups. Plasma-Lyte-A was similar to 0.9% Saline in time to resolution of DKA, need for RRT, mortality, and lengths of PICU and hospital stay.. Clinical trial registry of India, CTRI/2018/05/014042 (ctri.nic.in) (Retrospectively registered).

    Topics: Acute Kidney Injury; Child; Child, Preschool; Diabetic Ketoacidosis; Double-Blind Method; Female; Gluconates; Humans; India; Magnesium Chloride; Male; Pediatric Emergency Medicine; Potassium Chloride; Proportional Hazards Models; Prospective Studies; Saline Solution; Sodium Acetate; Sodium Chloride

2020

Other Studies

2 other study(ies) available for sodium-acetate--anhydrous and Diabetic-Ketoacidosis

ArticleYear
The causal link between hyperchloremia and acute kidney injury is yet to be conclusively established: we are not sure.
    Critical care (London, England), 2020, 05-28, Volume: 24, Issue:1

    Topics: Acute Kidney Injury; Child; Diabetic Ketoacidosis; Double-Blind Method; Gluconates; Humans; Magnesium Chloride; Potassium Chloride; Saline Solution; Sodium Acetate; Sodium Chloride

2020
Plasma-Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosis.
    Journal of critical care, 2012, Volume: 27, Issue:2

    The purpose of the study was to determine the effects of Plasma-Lyte 148 (PL) vs 0.9% saline (NS) fluid resuscitation in diabetic ketoacidosis (DKA).. A multicenter retrospective analysis of adults admitted for DKA to the intensive care unit, who received almost exclusively PL or NS infusion up until 12 hours, was performed.. Nine patients with PL and 14 patients with NS were studied. Median serum bicarbonate correction was higher in the PL vs NS groups at 4 to 6 hours (8.4 vs 1.7 mEq/L) and 6 to 12 hours (12.8 vs 6.2 mEq/L) from baseline (P < .05). Median standard base excess improved by 10.5 vs 4.2 mEq/L at 4 to 6 hours and by 16.0 vs 9.1 mEq/L at 6 to 12 hours in the PL and NS groups, respectively (P < .05). Chloride levels increased significantly in the NS vs PL groups over 24 hours. Potassium levels were lower at 6 to 12 hours in the PL group. Mean arterial blood pressure was higher at 2 to 4 hours in the PL group, whereas cumulative urine output was lower at 4 to 6 hours in the NS group. There were no differences in glycemic control or duration of intensive care unit stay.. Patients with DKA resuscitated with PL instead of NS had faster initial resolution of metabolic acidosis and less hyperchloremia, with a transiently improved blood pressure profile and urine output.

    Topics: Adult; Diabetic Ketoacidosis; Female; Fluid Therapy; Gluconates; Humans; Intensive Care Units; Magnesium Chloride; Male; Middle Aged; Potassium Chloride; Resuscitation; Retrospective Studies; Sodium Acetate; Sodium Chloride; Treatment Outcome; Young Adult

2012